Breaking News

Thursday Show Full Stories X To view all stories in expanded form, please subscribe. Get Free Trial Send Info
ADIL Adial Pharmaceuticals $2.62 (0.00%) 07:24 10/11/18 10/11 07:24 10/11/18 07:24 Initiation	Adial Pharmaceuticals initiated at Dawson James » Adial Pharmaceuticals… Adial Pharmaceuticals initiated with a Buy at Dawson James. Dawson James analyst Carol Werther initiated Adial Pharmaceuticals with a Buy and $6 price target. 03/08/13 Wedge Partners 03/08/13 Credit Suisse 03/06/13 Citigroup 03/06/13 Barclays See Street Research during your Free Trial

Over a week ago
HSDT Helius Medical $9.40 -0.4 (-4.08%) , PDVW pdvWireless $33.93 0.03 (0.09%) … 04:55 10/02/18 10/02 04:55 10/02/18 04:55 Conference/Events	PubCoCEO to hold a conference » MicroCap Conference 2018… MicroCap Conference 2018 will be held in New York on October 1-2. HSDT Helius Medical $9.40 -0.4 (-4.08%) PDVW pdvWireless $33.93 0.03 (0.09%) ADIL Adial Pharmaceuticals $2.76 -0.24 (-8.00%) NAKD Naked Brand Group $2.41 -0.29 (-10.74%) OGEN Oragenics $1.60 0.46 (40.35%) CURR CURE Pharmaceutical $0.00 (0.00%) JTPY JetPay $2.10 0.1 (5.00%) ISDR Issuer Direct $15.31 -0.64 (-4.01%) INPX Inpixon $0.21 0.0031 (1.54%) XXII 22nd Century $2.78 -0.03 (-1.07%) PRLX Parlex Corp. $0.00 (0.00%) KMDA Kamada $6.22 0.065 (1.06%) LMAT LeMaitre $37.24 -1.48 (-3.82%) DXR Daxor $5.44 0.18 (3.42%) SNOA Sonoma Pharmaceuticals $1.54 (0.00%) 03/08/13 Wedge Partners 03/08/13 Credit Suisse 03/06/13 Citigroup 03/06/13 Barclays See Street Research during your Free Trial	02 Oct 04 Oct 04 Oct 05 Oct
ADIL Adial Pharmaceuticals $3.00 (0.00%) 14:32 10/01/18 10/01 14:32 10/01/18 14:32 Initiation	Adial Pharmaceuticals initiated at Dawson James » Adial Pharmaceuticals at… Adial Pharmaceuticals at Dawson James. Dawson James initiated Adial Pharmaceuticals with a Buy and $6 price target. 03/08/13 Wedge Partners 03/08/13 Credit Suisse 03/06/13 Citigroup 03/06/13 Barclays See Street Research during your Free Trial	01 Oct
HSDT Helius Medical $9.80 0.34 (3.59%) , PDVW pdvWireless $33.90 -1.65 (-4.64%) … 07:24 10/01/18 10/01 07:24 10/01/18 07:24 Conference/Events	PubCoCEO to hold a conference » MicroCap Conference 2018… MicroCap Conference 2018 will be held in New York on October 1-2. HSDT Helius Medical $9.80 0.34 (3.59%) PDVW pdvWireless $33.90 -1.65 (-4.64%) ADIL Adial Pharmaceuticals $3.00 0.03 (1.01%) NAKD Naked Brand Group $2.70 -0.03 (-1.10%) OGEN Oragenics $1.14 0.4225 (58.89%) CURR CURE Pharmaceutical $0.00 (0.00%) JTPY JetPay $2.00 0.2 (11.11%) ISDR Issuer Direct $15.95 0.95 (6.33%) INPX Inpixon $0.20 -0.01 (-4.72%) XXII 22nd Century $2.81 -0.03 (-1.06%) PRLX Parlex Corp. $0.00 (0.00%) KMDA Kamada $6.15 -0.1 (-1.60%) LMAT LeMaitre $38.72 1.23 (3.28%) DXR Daxor $5.26 -0.24 (-4.36%) SNOA Sonoma Pharmaceuticals $1.54 0.04 (2.67%) 03/08/13 Wedge Partners 03/08/13 Credit Suisse 03/06/13 Citigroup 03/06/13 Barclays See Street Research during your Free Trial	01 Oct 01 Oct 02 Oct 04 Oct 04 Oct 05 Oct
ADIL Adial Pharmaceuticals $3.13 0.3 (10.60%) 07:35 09/18/18 09/18 07:35 09/18/18 07:35 Hot Stocks	Adial Pharmaceuticals receives European patent for AD04 » Adial Pharmaceuticals… Adial Pharmaceuticals announced an addition to its intellectual property, or IP portfolio, as it has successfully passed the patent opposition period in Europe without any challenges to its patent for AD04, which was granted by the European Patent Office, or EPO, as EP 2801625 B1 and validated in 36 European countries. With the opposition period having expired, a third party can no longer challenge the validity of EP 2801625 B1 in the EPO. This patent can now only be challenged in the individual national courts of the 36 European countries where it has been validated. The company believes the claims and scope of the patent are highly enforceable and provide broad protection. 03/08/13 Wedge Partners 03/08/13 Credit Suisse 03/06/13 Citigroup 03/06/13 Barclays See Street Research during your Free Trial

Over a month ago
ADIL Adial Pharmaceuticals $2.76 -0.14 (-4.83%) 09:18 09/12/18 09/12 09:18 09/12/18 09:18 Hot Stocks	Adial Pharmaceuticals announces 'successful' stability results for AD04 » Adial Pharmaceuticals… Adial Pharmaceuticals announced "successful" results related to the stability testing of the clinical trial material for its lead drug candidate, AD04, a genetically targeted therapeutic agent being developed to treat alcohol use disorder. The program indicated stability at the four-year time point for both the active drug candidate and the placebo tablets that had been previously manufactured for use in clinical trials. 03/08/13 Wedge Partners 03/08/13 Credit Suisse 03/06/13 Citigroup 03/06/13 Barclays See Street Research during your Free Trial
ADIL Adial Pharmaceuticals $3.85 0.44 (12.90%) 09:11 08/15/18 08/15 09:11 08/15/18 09:11 Hot Stocks	Adial Pharmaceuticals appoints Monika Rogozinska as senior VP » Adial Pharmaceuticals… Adial Pharmaceuticals announced the appointment of Monika Rogozinska as senior VP of drug and business development. Prior to joining Adial, Rogozinska served as VP and Head of portfolio, program & project management at ECRC in Boston, where she managed a portfolio of complex projects as the clinical contact and spokesperson for potential licensing, acquisition, collaborations, co-development agreements and strategic alliances. 03/08/13 Wedge Partners 03/08/13 Credit Suisse 03/06/13 Citigroup 03/06/13 Barclays See Street Research during your Free Trial
ADIL Adial Pharmaceuticals $0.00 (0.00%) 07:42 07/27/18 07/27 07:42 07/27/18 07:42 Syndicate	Adial Pharmaceuticals 1.46M share Secondary priced at $5.00 » Joseph Gunnar acted as… Joseph Gunnar acted as sole book running manager for the offering. 03/08/13 Wedge Partners 03/08/13 Credit Suisse 03/06/13 Citigroup 03/06/13 Barclays See Street Research during your Free Trial

On The Fly

News and insights, exclusive to thefly.com

20:25	Notable companies reporting before tomorrow's open»
18:58	Fly Intel: After Hours Movers»
16:25	Fly Intel: Wall Street's top stories for Monday»
14:12	Fly Intel: What to watch in Johnson & Johnson earnings report»
13:54	Barclays remains bullish on GE, says earnings date push-back 'not a negative'»

View all On The Fly Stories »

Upcoming
Events (10)

ITUS	Pre-IND Meeting with FDA & ITUS Corp
MOR	Annual Healthcare Investor Conference
XLNX ...	Arm TechCon 2018
	34th Annual FIA Futures & Options Expo
A ...	ASHG Conference 2018
CDAY	INSIGHTS 2018
	Fuel Oil Summit
	2018 HCIT & Distribution Roundtable
	Gartner Symposium: ITxpo 2018
	Adobe MAX

View all of today’s events »

Today’s
Syndicate (0)

No syndicate deals for your search.

View this week’s syndicate »

Get Full Fly Access

Breaking market intelligence sent straight to you: Our team of experts analyze every news story and filter out the noise to deliver real-time market moving news.

Up-to-date information on important industry events: Get real-time updates on events that are moving the market—from conferences and calls to syndicate announcements.

News focused on the companies in your portfolio: Create up to 12 portfolios with 150 stocks each, and see how active they are in market news.

14 Day Free Trial